Abstract

Question: Should the BCG vaccine be given universally to all neonates at birth in a population with high prevalence for HIV to mitigate the risk of severe TB disease or should vaccination be delayed until HIV status is known?

  • Population: Neonates in a population with high prevalence of HIV
  • Intervention: One dose of BCG vaccine given at birth.
  • Comparison(s): Delaying BCG vaccination.
  • Outcome: Prevention of severe TB disease
  • Evidence to recommendation table
  • Tuberculosis